Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study
Ischemic stroke patients with diabetes are at high risk for recurrent stroke and cardiovascular complications. Pioglitazone, a type of thiazolidinedione, has been shown to reduce cardiovascular complications i...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Joonsang Yoo, Jimin Jeon, Minyoul Baik and Jinkwon Kim Tags: Research Source Type: research
More News: Actos | Cardiology | Cardiovascular | Diabetes | Endocrinology | Heart | Ischemic Stroke | Stroke | Study